Why there are two terms for the same thing
When SSRIs were first introduced in the 1980s and 1990s, the pharmaceutical industry and some clinicians were reluctant to use the word "withdrawal" — a term associated with addiction and dependence. Instead, the term "discontinuation syndrome" was adopted to describe the symptoms that occur when SSRIs are stopped or reduced.
The rationale was that SSRIs do not produce the same reinforcing, addictive properties as substances like opioids or benzodiazepines — and therefore the word "withdrawal" was considered misleading. This distinction was clinically defensible in a narrow technical sense, but it had a significant practical consequence: patients and many clinicians underestimated the severity and duration of symptoms because the softer terminology implied something minor and temporary.
What "discontinuation syndrome" actually means
Discontinuation syndrome refers specifically to the cluster of symptoms that arise when an antidepressant is stopped or the dose is significantly reduced. The symptoms are broadly the same regardless of which term is used:
- Brain zaps, dizziness, nausea, flu-like symptoms
- Anxiety, irritability, mood instability
- Sleep disruption, vivid dreams
- Sensory disturbances, cognitive difficulties
The term is most commonly used in official prescribing information and some clinical guidelines. When your doctor or pharmacist refers to "SSRI discontinuation syndrome", they are describing the same experience that patients typically call withdrawal.
What the debate is really about
The terminology debate reflects a deeper clinical and political disagreement about the nature of antidepressant dependence. The positions broadly are:
| Position | "Discontinuation syndrome" | "Withdrawal" |
|---|---|---|
| Implies | A temporary, self-limiting reaction | Physiological dependence requiring careful management |
| Duration suggested | Days to weeks | Weeks to months or longer |
| Severity acknowledged | Usually mild to moderate | Can be severe and prolonged |
| Dependence implied? | No | Yes — physiological, not behavioural |
| Prescriber response | Often: taper over weeks, symptoms will resolve | Often: requires months-long taper, specialist support |
What the evidence now shows
The growing body of research — and the updated position of NICE, the Royal College of Psychiatrists and other bodies — has shifted toward acknowledging that:
- Symptoms can be severe and prolonged, not just mild and brief
- The terminology "discontinuation syndrome" may have led to clinical underestimation of the problem
- Physiological dependence — the nervous system adapting to the medication and requiring careful readjustment — is real and should be acknowledged honestly
- The distinction from "addiction" remains valid (antidepressants do not produce craving, drug-seeking behaviour or euphoria) but should not be used to minimise genuine suffering
The NICE guideline on medicines associated with dependence and withdrawal (NG215, 2022) uses the language of "dependence and withdrawal" explicitly, marking a significant shift in the official clinical framing.
What this means for you in practice
If you are discussing antidepressant reduction with your GP or psychiatrist, you may encounter both terms. A few things worth knowing:
- If you are told that "discontinuation syndrome" is usually mild and brief — that is true for some people but not all. Long-term, higher-dose use is associated with more significant and prolonged symptoms
- If a clinician seems unfamiliar with the concept of prolonged withdrawal, referring them to NICE NG215 or the Royal College of Psychiatrists updated guidance on stopping antidepressants may be helpful
- The two terms describe the same physiological process — the debate is semantic and political, not clinical
Our approach
How we talk about withdrawal
We use the language of withdrawal and physiological dependence honestly — not because we want to alarm people, but because accurate framing leads to better clinical decisions. Minimising the experience does not help patients prepare for it or manage it effectively. We prefer honest, informed conversations about what to expect and why.
Book a ConsultationReferences
- Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychotherapy and Psychosomatics. 2015;84(2):72–81. DOI: 10.1159/000370338
- Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects. Addictive Behaviors. 2019;97:111–121. DOI: 10.1016/j.addbeh.2018.08.027
- National Institute for Health and Care Excellence. Medicines associated with dependence or withdrawal symptoms. NICE guideline NG215. London: NICE; 2022.
- Royal College of Psychiatrists. Position statement on antidepressants and depression. 2019. Available at: rcpsych.ac.uk
- Horowitz MA, Taylor D. The Maudsley Deprescribing Guidelines. Wiley-Blackwell; 2024. ISBN: 978-1119822981
Related reading
The word matters less than the clinical reality it describes.
Whether called withdrawal or discontinuation syndrome, the experience deserves to be taken seriously — and managed with the care and pacing it requires.